pyrazines has been researched along with Retinal Neovascularization in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; Li, J; Li, S; Liang, X; Liao, X; Luo, Y; Min, W; Sun, G; Yang, C; Zhou, H | 1 |
1 other study(ies) available for pyrazines and Retinal Neovascularization
| Article | Year |
|---|---|
TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model.
Topics: Animals; Animals, Newborn; Apoptosis; Disease Models, Animal; Drugs, Chinese Herbal; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Ligusticum; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Nerve Tissue Proteins; Neuroprotective Agents; Oxygen; Pyrazines; Reperfusion Injury; Retinal Neovascularization; Retinal Neurons; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2012 |